pubmed-article:9139600 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9139600 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
pubmed-article:9139600 | lifeskim:mentions | umls-concept:C1184738 | lld:lifeskim |
pubmed-article:9139600 | lifeskim:mentions | umls-concept:C1441616 | lld:lifeskim |
pubmed-article:9139600 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:9139600 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:9139600 | pubmed:dateCreated | 1997-5-8 | lld:pubmed |
pubmed-article:9139600 | pubmed:abstractText | 153 regional lymph nodes obtained during surgical operations because of cancer of various cites from 50 cancer patients were studied. Failure of local immunity is explained by the following factors: 1) depletion of T-cell population with a decrease of activated lymphocyte-killers; 2) high activity of B-cell population able to block T-cell cytotoxic effect; 3) deficiency of T-suppressors and T-helpers; 4) a decrease of macrophages-monocytes of phagocytic capacity; 5) high activity of dendritic reticular cells stimulating transformation of B-lymphocytes and low activity of interdigitating reticulocytes determining T-cell immunity stimulation. | lld:pubmed |
pubmed-article:9139600 | pubmed:language | rus | lld:pubmed |
pubmed-article:9139600 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9139600 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9139600 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9139600 | pubmed:issn | 0004-1955 | lld:pubmed |
pubmed-article:9139600 | pubmed:author | pubmed-author:PetrovS VSV | lld:pubmed |
pubmed-article:9139600 | pubmed:author | pubmed-author:TsyplakovD... | lld:pubmed |
pubmed-article:9139600 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9139600 | pubmed:volume | 59 | lld:pubmed |
pubmed-article:9139600 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9139600 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9139600 | pubmed:pagination | 12-9 | lld:pubmed |
pubmed-article:9139600 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:9139600 | pubmed:meshHeading | pubmed-meshheading:9139600-... | lld:pubmed |
pubmed-article:9139600 | pubmed:meshHeading | pubmed-meshheading:9139600-... | lld:pubmed |
pubmed-article:9139600 | pubmed:meshHeading | pubmed-meshheading:9139600-... | lld:pubmed |
pubmed-article:9139600 | pubmed:meshHeading | pubmed-meshheading:9139600-... | lld:pubmed |
pubmed-article:9139600 | pubmed:meshHeading | pubmed-meshheading:9139600-... | lld:pubmed |
pubmed-article:9139600 | pubmed:meshHeading | pubmed-meshheading:9139600-... | lld:pubmed |
pubmed-article:9139600 | pubmed:meshHeading | pubmed-meshheading:9139600-... | lld:pubmed |
pubmed-article:9139600 | pubmed:meshHeading | pubmed-meshheading:9139600-... | lld:pubmed |
pubmed-article:9139600 | pubmed:meshHeading | pubmed-meshheading:9139600-... | lld:pubmed |
pubmed-article:9139600 | pubmed:meshHeading | pubmed-meshheading:9139600-... | lld:pubmed |
pubmed-article:9139600 | pubmed:meshHeading | pubmed-meshheading:9139600-... | lld:pubmed |
pubmed-article:9139600 | pubmed:meshHeading | pubmed-meshheading:9139600-... | lld:pubmed |
pubmed-article:9139600 | pubmed:meshHeading | pubmed-meshheading:9139600-... | lld:pubmed |
pubmed-article:9139600 | pubmed:meshHeading | pubmed-meshheading:9139600-... | lld:pubmed |
pubmed-article:9139600 | pubmed:meshHeading | pubmed-meshheading:9139600-... | lld:pubmed |
pubmed-article:9139600 | pubmed:articleTitle | [Cancer and the regional lymph nodes (immunohistochemical and ultrastructural studies)]. | lld:pubmed |
pubmed-article:9139600 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9139600 | pubmed:publicationType | English Abstract | lld:pubmed |